Evaluation of therapeutic potential of VB-001, a leave-on formulation, for the treatment of moderate adherent dandruff

Table 4 Treatment success in both groups

Efficacy Parameter	VB-001 (N = 78)	ZPTO shampoo (N = 81)	P value
Mean ASFS (normalized) difference (Baseline-Day 14)	75.6%	67.9%	0.0005^a
Mean pruritus score (normalized) difference (Baseline-Day 9)	75%	61%	0.03^a
Mean scalp related quality of life index score difference (Baseline-Day 14)	51.6%	45.1%	0.03^b
Visible hair fall reduction at day 14 (% of subjects)	41%	18.5%	<0.05^c
Softness at day 14 (% of subjects)	83.3%	67.9%	<0.05^c

^aSignificant by t-test; ^bSignificant by ANOVA Kruskal Wallis; ^cSignificant by Chi square test

ISSN: 1471-5945